Literature DB >> 25922315

Evaluation of Quality of Lower Limb Arthroplasty Observational Studies Using the Assessment of Quality in Lower Limb Arthroplasty (AQUILA) Checklist.

James B Cowan1, Ryan A Mlynarek1, Rob G H H Nelissen2, Bart G C W Pijls2, Joel J Gagnier3.   

Abstract

UNLABELLED: This study used the assessment of quality in lower limb arthroplasty (AQUILA) checklist to assess the quality of lower limb arthroplasty observational studies. Among 132 studies the mean reporting quality score was 5.4 (SD=1.2) out of 8 possible points. Most studies adequately reported reasons for revisions (98%) and prosthesis brand and fixation (95%) in sufficient detail. Only 3% of studies adequately reported the number of patients unwilling to participate, 15% stated a clear primary research question or hypothesis, 11% reported a worst-case analysis or competing risk analysis for endpoints, and 42% reported more than 5% of patients were lost to follow-up. There is significant room for improvement in the reporting and methodology of lower limb arthroplasty observational studies. LEVEL OF EVIDENCE: Level III.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AQUILA checklist; lower limb arthroplasty; observational studies; research methodology

Mesh:

Year:  2015        PMID: 25922315     DOI: 10.1016/j.arth.2015.03.020

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

Review 1.  Conversion from knee arthrodesis to arthroplasty: systematic review.

Authors:  Willem Alexander Kernkamp; Wiebe Christiaan Verra; Bart Godefridus Pijls; Jan Wilhelmus Schoones; Henrica Maria Jannetta van der Linden; Rob Gerardus Henricus Hubertus Nelissen
Journal:  Int Orthop       Date:  2016-03-16       Impact factor: 3.075

2.  Debridement, Antibiotics, and Implant Retention with the Direct Anterior Approach for Acute Periprosthetic Joint Infection Following Primary THA.

Authors:  R L Deijkers; E P M van Elzakker; B G Pijls
Journal:  JB JS Open Access       Date:  2020-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.